All Pharma News
Pasithea`s Announces Completion of Enrollment PAS-004 in Ongoing Ph1 Trial

Pasithea`s Announces Completion of Enrollment PAS-004 in Ongoing Ph1 Trial
GLOBENEWSWIRE
13 Jun 2024
Share Share
Pasithea: Preclinical Data On PAS-004 Inhibiting NRAS Cancer At ASCO 2024

Pasithea: Preclinical Data On PAS-004 Inhibiting NRAS Cancer At ASCO 2024
GLOBENEWSWIRE
28 May 2024
Share Share
Pasithea PAS-004 Abstract at ASCO 2024

Pasithea PAS-004 Abstract at ASCO 2024
GLOBENEWSWIRE
29 Apr 2024
Share Share
Pasithea Completes Initial PAS-004 Cancer Trial Dosing

Pasithea Completes Initial PAS-004 Cancer Trial Dosing
GLOBENEWSWIRE
24 Apr 2024
Share Share
Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004

Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004
GLOBENEWSWIRE
08 Jan 2024
Share Share
Pasithea Announces Adjournment of Reconvened Meeting of Stockholders

Pasithea Announces Adjournment of Reconvened Meeting of Stockholders
GLOBENEWSWIRE
28 Dec 2023
Share Share
Pasithea Therapeutics Announces Results from 2023 Annual Meeting

Pasithea Therapeutics Announces Results from 2023 Annual Meeting
GLOBENEWSWIRE
19 Dec 2023
Share Share
Pasithea Announces Positive In Vivo Preclinical Efficacy Data for PAS-004

Pasithea Announces Positive In Vivo Preclinical Efficacy Data for PAS-004
GLOBENEWSWIRE
11 Dec 2023
Share Share
Pasithea Therapeutics Corp. Announces Final Results of Tender Offer

Pasithea Therapeutics Corp. Announces Final Results of Tender Offer
GLOBENEWSWIRE
14 Sep 2023
Share Share
Pasithea to Participate in H.C. Wainwright 25th Annual Investment Conference

Pasithea to Participate in H.C. Wainwright 25th Annual Investment Conference
GLOBENEWSWIRE
07 Sep 2023
Share Share